Initial evidence supporting the involvement of inflammation in obesity and T2D came from the finding that the pro-inflammatory molecule tumor necrosis factor-alpha (TNF-α) features increased expression in adipose tissue (AT) from obese rodents and humans with amelioration of IR after neutralization of this potent cytokine [6,7]. The gene discussed is TNF; the disease is Obesity.